REYATAZ

Medicinal product

(Invented) name

REYATAZ

Active substance (s)

Atazanaviras

Strength

150 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AE08, Atazanavir

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2004-03-02

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Capsule, hard	1 vnt.
Atazanaviras	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
28171	30706	1030706	buteliukas	N60		Receptinis	EU/1/03/267/003	Netiekiama	-	-	No	-	-
28172	30707	1030707	lizdinė plokštelė	N60		Receptinis	EU/1/03/267/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-09-05	Išregistruotas
2004-03-02	Registruotas